Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Treatment of Fully Resected Stage III Colon Cancer With FOLFOX-4 Versus FOLFOX-4 Plus Cetuximab

NCT00265811 is registered in ClinicalTrials.gov with Federation Francophone de Cancerologie Digestive as lead sponsor.

NCT NCT00265811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00265811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Treatment of Fully Resected Stage III Colon Cancer With FOLFOX-4 Versus FOLFOX-4 Plus Cetuximab
Lead sponsor
Federation Francophone de Cancerologie Digestive
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2005
Completion date
June 22, 2010
Enrollment
2,559 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer